These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 7609061

  • 1. PREPs: herpes simplex virus type 1-specific particles produced by infected cells when viral DNA replication is blocked.
    Dargan DJ, Patel AH, Subak-Sharpe JH.
    J Virol; 1995 Aug; 69(8):4924-32. PubMed ID: 7609061
    [Abstract] [Full Text] [Related]

  • 2. The effect of herpes simplex virus type 1 L-particles on virus entry, replication, and the infectivity of naked herpesvirus DNA.
    Dargan DJ, Subak-Sharpe JH.
    Virology; 1997 Dec 22; 239(2):378-88. PubMed ID: 9434728
    [Abstract] [Full Text] [Related]

  • 3. Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.
    Pomeranz LE, Blaho JA.
    J Virol; 2000 Nov 22; 74(21):10041-54. PubMed ID: 11024133
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HSV molecular biology: general aspects of herpes simplex virus molecular biology.
    Subak-Sharpe JH, Dargan DJ.
    Virus Genes; 1998 Nov 22; 16(3):239-51. PubMed ID: 9654678
    [Abstract] [Full Text] [Related]

  • 6. Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure.
    Sun M, Zhang GR, Yang T, Yu L, Geller AI.
    Hum Gene Ther; 1999 Aug 10; 10(12):2005-11. PubMed ID: 10466634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells.
    Rixon FJ, Addison C, McLauchlan J.
    J Gen Virol; 1992 Feb 10; 73 ( Pt 2)():277-84. PubMed ID: 1311357
    [Abstract] [Full Text] [Related]

  • 9. PREPS and L-particles: a new approach to virus-like particle vaccines.
    Pardoe I, Dargan D.
    Expert Rev Vaccines; 2002 Dec 10; 1(4):427-32. PubMed ID: 12901580
    [Abstract] [Full Text] [Related]

  • 10. Virus particles produced by the herpes simplex virus type 1 alkaline nuclease null mutant ambUL12 contain abnormal genomes.
    Porter IM, Stow ND.
    J Gen Virol; 2004 Mar 10; 85(Pt 3):583-591. PubMed ID: 14993641
    [Abstract] [Full Text] [Related]

  • 11. Qualitative Differences in Capsidless L-Particles Released as a By-Product of Bovine Herpesvirus 1 and Herpes Simplex Virus 1 Infections.
    Russell T, Bleasdale B, Hollinshead M, Elliott G.
    J Virol; 2018 Nov 15; 92(22):. PubMed ID: 30185590
    [Abstract] [Full Text] [Related]

  • 12. A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells.
    Desai PJ.
    J Virol; 2000 Dec 15; 74(24):11608-18. PubMed ID: 11090159
    [Abstract] [Full Text] [Related]

  • 13. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
    Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ.
    Antiviral Res; 2006 Dec 15; 72(3):242-51. PubMed ID: 16876885
    [Abstract] [Full Text] [Related]

  • 14. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function.
    Johnson PA, Wang MJ, Friedmann T.
    J Virol; 1994 Oct 15; 68(10):6347-62. PubMed ID: 8083974
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of herpes simplex virus type 1 immediate-early gene expression by alpha interferon is not VP16 specific.
    Nicholl MJ, Preston CM.
    J Virol; 1996 Sep 15; 70(9):6336-9. PubMed ID: 8709261
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A network of protein interactions around the herpes simplex virus tegument protein VP22.
    Maringer K, Stylianou J, Elliott G.
    J Virol; 2012 Dec 15; 86(23):12971-82. PubMed ID: 22993164
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.